Older Cancer Patients Skip Clinic Tests
Posted on: Friday, 12 November 2004, 21:00 CST
Only 36 percent of U.S. cancer patients 65 and older take part in clinical trials despite making up 60 percent of the cancer population.
That's the word in a new government study, to be published Monday in the Journal of Clinical Oncology.
If elderly patients do not participate in clinical trials, the treatments resulting from those trials may not be appropriate for them, said Dr. Lilia Talarico, of the Food and Drug Administration and lead author of the study. This is a significant concern, given that elderly patients represent the majority of cancer patients in the U.S.
Researchers performed a retrospective analysis of 28,766 people in 55 clinical trials of new cancer drugs or new indications of already approved drugs from 1995 to 2002.
Data on trials for the treatment of leukemia, lymphoma and cancers of the breast, lung, colon, ovary, pancreas and central nervous system were analyzed by age groups.
Source: United Press International
Related Articles
- NCI Renews Mayo Clinic Cancer Center Support Grant, Extends Comprehensive Status
- Rexinoid Developed By NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
- Enzon's PEG-SN38 Featured in Clinical Cancer Research
- Novacea's Proof-of-Principle Study of AQ4N in Solid Tumors Published in Clinical Cancer Research
- MEDecision's Patient Clinical Summary To Be Implemented By Memphis Managed Care Corporation
- Clinical Cancer Research Publishes Paper Comparing CTCs to Imaging in Predicting Overall Survival in Metastatic Breast Cancer
- Application of Sentinel Principle in Bladder Cancer Published in Clinical Cancer Research
- Radical surgery best option for most ovarian cancer patients with cancer in diaphragm
- Clinical Trial for Pancreatic Cancer Opens at Mayo Clinic Using Tumor-Targeted Gene Therapy Vector
- A.P. Pharma Initiates APF530 Phase 2 Clinical Trial Program in Cancer Patients
 |
 |
User Comments (0)
RSS Feeds